Regulatory Updates
Sep 14, 2026•3 min read
Health Canada adds viral reactivation warning to TZIELD product monograph
Health Canada now contraindicates TZIELD in patients with active EBV or CMV infection, severe lymphopenia, or who are immunocompromised.
Regulatory Updates
Aug 29, 2026•3 min read
South Korea Introduces New ‘Pancreas Disability’ Category Effective July 1
From July 1, South Korea will recognize severe pancreatic dysfunction as a new disability category, benefiting type 1 diabetes patients. A ceremony will mark the first Pancreas Disability Day.